Pursuit of a Chiral Amino Aldehyde Intermediate in the Synthesis of (+)-Obafluorin, a B-Lactone Antibiotic by Cwik \u2796, Jim
Illinois Wesleyan University
Digital Commons @ IWU
Honors Projects Chemistry
1996
Pursuit of a Chiral Amino Aldehyde Intermediate
in the Synthesis of (+)-Obafluorin, a B-Lactone
Antibiotic
Jim Cwik '96
Illinois Wesleyan University
This Article is brought to you for free and open access by The Ames Library, the Andrew W. Mellon Center for Curricular and Faculty
Development, the Office of the Provost and the Office of the President. It has been accepted for inclusion in Digital Commons @ IWU by
the faculty at Illinois Wesleyan University. For more information, please contact digitalcommons@iwu.edu.
©Copyright is owned by the author of this document.
Recommended Citation
Cwik '96, Jim, "Pursuit of a Chiral Amino Aldehyde Intermediate in the Synthesis of (+)-Obafluorin, a B-Lactone
Antibiotic" (1996). Honors Projects. Paper 15.
http://digitalcommons.iwu.edu/chem_honproj/15
Pursuit of a Chiral Amino Aldehyde Intermediate
 
in the Synthesis of (+)-Obafluorin, a
 
p-Lactone Antibiotic
 
Jim Cwik 
Dr. Jeffrey A. Frick, Research Advisor 
Submitted in Partial Fulfillment of the Requirement
 
for Research Honors in Chemistry and Chemistry 499
 
Illinois Wesleyan University
 
April 26, 1996
 
-Table of Contents
 
I. 
II. 
III. 
IV. 
V. 
VI. 
VII. 
VIII. 
List of Spectral Data , 2
 
Abstract. 3
 
Background 4
 
Introduction 6
 
Experimental 10
 
Discussion 13
 
Future Work 17
 
References 18
 
1
 
-List of Spectral Data
 
IR Spectrum of N-Protected BOC-L-Serine (18b) A-I
 
I H NMR Spectrum of N-Protected BOC-L-Serine (18b) A-2, A-3
 
IR Spectrum of L-Serine ~-Lactone Tosylate
 
IR Spectrum of Reaction between N-Protected CBZ-L-Serine
 
IR Spectrum of N-Protected CBZ-L-Serine
 
~-Lactone (19a) in Methanol. A -9
 
IR Spectrum of Reaction of L-Serine ~-Lactone Tosylate
 
Salt (20) with 9-Bromo-9-phenylfluorene A-I 0
 
IR Spectrum of N-Protected BOC-L-Serine ~-Lactone (19b) A-4
 
Salt (20)from N-Protected BOC-L-Serine ~-Lactone (19b) A-5
 
IR Spectrum of CBZ-L-Serine ~-Lactone (19a) .........•.....................•A-6, A-7
 
~-Lactone (19a) and p-Toluenesulfonic Acid A- 8
 
2
 
• 
Abstract 
This research is focused on synthesizing a chiral amino 
aldehyde from L-Serine. The proposed synthesis of the amino 
aldehyde would yield a stereochemically pure product working 
through an L-Serine ~-lactone intermediate. The amino aldehyde IS a 
proposed intermediate in the synthesis of (+)-obafluorin, a ~ -lactone 
antibiotic of interest. The proposed synthesis might provide a 
simpler, more versatile way to synthesize obafluorin. 
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-Background 
In 1982, Wells et al) were conducting experiments on a variety of 
organisms to test for the presence of novel molecules containing the fl­
lactam (1) moiety. Some naturally occuring antibiotics, including 
penicillin, were known to contain the fl-Iactam moiety and already many 
others had been isolated by searching for this structure. Most of the 
antibiotics' had been discovered from fungi and actinomycetes. In this 
case, the researchers took a different route and applied a highly selective 
test to detect the presence of fl-Iactams in bacteria. To their suprise, their 
results showed that not only had they discovered some fl-Iactams 
produced by the bacteria, but also fl-Iactones (2). The two structures have 
the same relative stereochemistry (the chiral atoms are indicated by a *), 
and differ in only one atom of the four-membered ring. 
CHzR
 
/T----N /T----O 
o o 
fl-lactam(1 ) fl-lactone(2) 
The sterochemistry of the fl-Iactams is extremely important to its role as 
an antibiotic. The fl-Iactams are inhibitors of D,D-carboxypeptidases, which 
catalyze a polymerization reaction in the formation of the cell wall in 
bacteria. If the inhibitor does not posess this stereochemistry, it will not 
fit into the active site of the enzyme and will not function.2 
One of the fl-Iactone molecules discovered in 1982 was produced by 
the bacteria Pseudomonas fluorescens and was identified as (+)-obafluorin 
(3) by Wells et al.3 in 1984. When tested by disk diffusion for its 
antibacterial activity, obafluorin was found to be about three times weaker 
than ampicillin, a fl-Iactam antibiotic. Also, it was the first fl-Iactone 
discovered that was susceptible to fl-Iactamases. Both these qualities . 
created interest in the molecule because it was apparently functioning by 
the same mechanism as the fl-Iactam antibiotics since it has the same 
4 
NH ~ ~./ { }-~2
,:: '\ f 
o 
HO OH J=1 
o 
(+)-Obafluorln(3) 
stereochemistry and was hydrolyzed by the same enzymes. This 
information spurred further research to discover its structure4 and to 
synthesize it. 
In addition to biosynthetic studies on obafluorinS,6, the first 
laboratory synthesis was reported in 1992 by Lowe, Pu, et al.,7 and again 
in 1994 by the same group.8 The latter synthesis was an improvement 
upon the first, and is represented by Scheme I. 
The synthesis started out with treatment of the imidazolidinone (4) 
with lithium hexamethyldisilylamide, followed by the addition of chloro 
[tris(diethylamino)] titanium to generate the titanium enolate (5). The 
addition of 4-nitrophenylacetaldehyde to the enolate produced two 
isomeric alcohols (not pictured). Acidic hydrolysis of the mixture, followed 
by ion exchange chromatography, produced pure threo ~-hydroxy a-amino 
acid (6 ). The resulting amino acid was protected on the nitrogen with (2­
nitrophenyl) sulfenyl chloride. The resulting protected amino acid (7) was 
converted to the N-protected ~-lactone (8) by addition of (4-bromophenyl) 
sulfonyl chloride in pyridine. The (2-nitrophenyl) sulfenyl group is then 
removed with thiocresol, and then transformed using p-toluenesulfonic 
acid (TsOR) into the tosylate salt (9). An acid chloride was then added to 
produce optically pure (+)-obafluorin. The reported yields ranged from 
>60% to >80%, except for the lactonization at 24%. This route proved to be a 
flexible one yielding some analogs that displayed antibacterial activity. 
The diversity of antibiotics is becoming a major issue today with the 
growing phenomenon of infectious diseases caused by organisms resistant 
to treatment. In an article appearing in the Chicago Tribune on January 
17th9, it was reported that 36 national and international medical journals 
that week had warned of overuse of antibiotics leading to resistant 
diseases. Joshua Lederberg, a Nobel laureate of Rockefeller University, 
warned that "the world's population had 'never been more vulnerable' 
5 
Scheme I 
o OTi(NEt2) 3 
fN-Me ~N-MeTiCI(NEt2) 3N~ -l/N ';../ ~ 
Bz ....t-Bu Bz ~t-Bu 
( 4 ) ( 5 ) 
1 OzN~ 
. ~CHO 
2. 6N HCI, reflux 
HN-SAr ~I
( 7 ) 
• 
NH2( 6 ) 
o 
HN-SAr 
( 8 ) 
TsOH 
to the threat of emerging and re-emerging diseases." 
As the number of resistant diseases grows, it is increasingly 
important that the diversity of antibiotics continues to grow also, so that 
medicine is given the necessary tools to fight today's changing diseases. 
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Introduction 
The purpose of this research was to find an alternate synthesis for 
obafluorin. The objectives were twofold. First, a synthesis that is more 
versatile is desired which would open up the possibility for different 
analogs of obafluorin than the ones that have been previously synthesized 
by Pu et aI.8 Second, a synthesis that begins with a molecule readily 
available from the chiral pool would be less wasteful than the Pu synthesis 
since it starts with a chiral auxillary. Scheme II represents the proposed 
synthesis. 
Scheme II 
o 
~H 
NH2 ),-~ 
( 1 0) o (11) 
1102 • 
y~ (12) 
o 
NOz 
----"""'1... 1-0 
~H (14) ~ (15) 
Pf Pf 
r.o2 
N~ 
~H (16) 
Pf 
~N ~ t! NH () 
____~.. rYHO 
Q-l0'1:t
t-Oz 0 
(3) 
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-The proposed synthesis begins with an amino acid, L-Serine ( 10). 
Through a series of reactions that will be discussed in further detail, it is 
converted to an N-protected chiral amino aldehyde (11). The anion of IT 
nitrotoluene is then added to the aldehyde. The resulting compound ( 1 2 ) 
is then treated with t-butyl dimethylsilyl chloride in order to protect the 
hydroxyl group from the subsequent oxidation reaction. After reduction of 
the oxazolidinone the amino alcohol (14) is converted to the amino acid 
(1 5) by oxidation. The hydroxyl group is then deprotected and the ~­
lactone (17) is formed. At this point the schemes I and II are identical, 
converting to the ~-lactone tosylate salt (9), and then to obafluorin (3). 
The present focus of this research has been to convert L-Serine (10) 
to the amino aldehyde (11). The following scheme outlines the reactions 
proposed for this conversion. 
Scheme III 
o
 
_C_BZ_-_C1-I." 1-0 /'.. Jl ()-l __T_P_P_..... I?
 
or ~ 'l' - DMAD ~ 
NHz BOCzO NH HN 0 
( 1 0) ~ ~ (19a R=CBZ) 
(18a R=CBZ) (19b R=BOC)!TFA (18b R=BOC) 
anh. TsOH 
DIBAL-H PfBrI? .. 
HN~ONH 
I I 
Pf (22) Pf (2 1 ) 
1CCI30CO,CCI3 
P)H 
a 'Pf 
( 1 1 ) 
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• 
L-Serine (10) is converted to the N-protected L-Serine ( 18b) by the 
addition of di-r-butyl dicarbonate. Lactonization takes places upon the 
addition of triphenylphosphine (TPP) and dimethylhydrazodicarboxylate 
(DMAD). The ~-lactone tosylate salt (20) is formed by adding 
. trifluoroacetic acid and anhydrous TsOH. To the tosylate salt 9-Bromo-9­
phenylfluorene in nitromethane are added to hopefully produce the N­
protected~-lactone (21). Reduction should occur upon addition of 
diisobutylaluminum hydride (DIBAL-H), and is followed by triphosgene to 
produce the stereochemically pure chiral amino aldehyde ( 11 ). 
9
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Experimental 
General Information. All solvents used were reagent grade solvents and 
purchased from Fisher Scientific. All chemicals used in reactions were 
pur~hased from Aldrich Chemical Co, except for N-protected 
benzyloxycabonyl (CBZ)-L-serine 13-lactone and 9-bromo-9-phenyltluorene 
which were obtained from previous researchers. A procedure for making 
the CBZ-Iactone is outlined in Arnold et al.l0 A procedure for the synthesis 
of 9-bromo-9-phenylfluorene can be found in Lubell et al.l 1 IR spectra 
were taken on an ATI Mattson Gensis Series Fourier Transform Infrared 
Spectrometer. NMR spectra were taken at Illinois State University on a 
Varian XL-300MHz Nuclear Magnetic Resonance Spectrometer. Reactions 
carried out under N2 were done with a balloon/septum set-up. Methods 
for purification of solvents and reagents were found in Perrin et al.l2 TPP 
was recrystallized from ethanol and dried under vacuum for 72 hrs. in the 
presence of phosphorous pentoxide. Tetrahydrofuran (THF) was dried by 
adding 3 3/4 in. cubes of sodium and 5 grams of benzophenone to 800 mL 
ofTHF under N2, and stirring with heat until a yellow to dark blue color 
change was observed. The THF was distilled from this mixture when 
needed. The monohydrate TsOH was dried by azeotropically distilling it 
from benzene, dissolved with the aid of ethyl acetate. Once the water was 
removed, the volume was distilled down to 10-15 mL and the acid was. 
precipitated by the addition of excess benzene along with cooling. The 
crystals were filtered, dried under vacuum, and stored in a dessicator, 
limiting exposure to air as much as possible. A m.p. of anywhere between 
94-98 Dc was suitable for reaction. Diethyl ether was dried using 
sodium/benzophenone. Trifluoroacetic acid (TFA) ,nitromethane and 
triethylamine were distilled. 
Synthesis ofN-Protected ROC-serine (18b). A solution of di-t-butyl 
dicarbonate (13.10 g, 0.120 mol) in dioxane (200 mL) was added to an ice­
cold, magnetically stirred solution of L-serine (10.50 g, 0.100 mol) in 1 N 
NaOH (100 mL) and was allowed to stir at 0 Dc for 1/2 hr. The reaction 
was then stirred at room temperature for 4 hrs, and monitored by TLC. 
After the reaction had gone to completion, the mixture was rotovaped at 
40 Dc to 1/2 its volume. The mixture was then cooled in an ice bath and 
acidified to pH 2-3 by adding 200 mL of IN KHS04. This mixture was 
extracted with ethyl acetate (3 X 125 mL), and the organic layers were 
10
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pooled and dried over anhydrous Na2~4. The ethyl acetate was filtered 
and rotovaped down to a yellow oiL The product was crystallized from 
ethyl acetate/hexane, and dried under vacuum. A 21% yield was 
obtained. Rf=0.80, 8:1:1 butanol/acetic acid/H20, nihydrin stain. m.p.90­
91 0( (dec) [std. m.p. 91 0( (dec) 13]; IR (KBr) 3420, 2981,1755, 1665, 1526, 
1158 cm-1 (Appendix A-I); 1H NMR (CD30D) b 4.96 (s,IH), 4.19 (s,IH), 
3.84 (dd, 2H) ppm (Appendix A-2, A-3). 
Synthesis ofN-Protected ROC-L-Serine f3-1actone (19b). To a magnetically 
stirred solution of anhydrous TPP in dry THF (44 mL) at -78 0C was added 
DMAD (l,45 mL, 13.1 mmol) dropwise over 10 min. A solution of BOC-L­
serine (2.50 g, 13.1 mmol) in dry THF (44 mL) was then added to the 
mixture dropwise over 15 min. The mixture was stirred for 20 min. at 
-78 0(, and then for 3 hrs. at room temperature. The reaction was 
monitored by TLC. The product was easily identified by TLC because it 
turned a bright yellow against a green background upon staining and 
heating. The reaction was rotovaped down to an oil and purified by 
column chromatography (90 g silica gel/6 hexane:4 ethyl acetate). 
Fractions containing the product were rotovaped to produce a yellow oil, 
which was crystallized from ethyl acetate/hexane. A 67% yield was 
obtained. Rf=0.50, 6:4 hexane/ethyl acetate, bromcresol green stain. m.p. 
119.5-120.50( (dec) [119.5-120.50( lit.value14]; IR (KBr) 3358, 1844, 
1680, 1532 cm- l (Appendix A-4) [3358, 1836, 1678, 1533 cm- l ]14. 
Synthesis ofL-Serine f3-Lactone Tosylate Salt (20) from BOC-Serine f3­
Lactone (19b). BOC-serine (3-lactone (605 mg, 3.23 mmol) and anhydrous 
TsOH were treated with distilled TFA at 00( for 15 min. The reaction was 
then rotovaped to remove the solvent, leaving a cream-colored solid. The 
solid was washed with dry diethyl ether, leaving a white solid, which was 
dried under vacuum. A 97% yield was obtained. Rf=O.O, ethyl acetate, 
bromocresol green stain. m.p. 131-132.5 °C (darken),155-160 0( (dec) 
[133-135 0( (darken),173 0( (rapid dec) 14,15]; IR (KBr) 3040, 1835, 1601, 
1527 cm- l (Appendix A-5) [IR (fluorolube mull) 3040, 1833, 1547 
cm- l ]14,15. 
11 
-Attempted Synthesis ofL-Serine f3-Lactone Tosylate Salt (20) from CBZ­
Serine f3-Lactone (19a). CBZ-L-Serine f3-lactone (0.100 g, 00452 mmol), 
anhydrous TsOR (0.100 g, 0.526 mmol), palladium on charcoal (catalytic), 
and anhydrous methanol (10 mL) were added together and stirred 
magnetically. The mixture was stirred for 5 hrs. and monitored by TLC. 
The mixtu'te was then filtered with celite, and the filtrate was rotovaped to 
produce white crystalline solid. 
Attempted Synthesis ofN-Protected 9-Phenylfluorenyl-L-Serine f3-Lactone 
(21). BOC-L-serine tosylate salt (0.290 g, 1.10 mmol) and 9-bromo-9­
phenylfluorene (00420 g, 1.30 mmol) were dissolved in distilled 
nitromethane (4 mL) and treated with triethylamine (044 mL, 3.10 mmol). 
The mixture was allowed to stir for 72 hrs. and turned light brown. The 
solvent was rotovaped down to produce a yellow oil. Ethyl acetate was 
added to precipitate a solid by product, the mixture was filtered, and the 
filtrate was rotovaped to produce a yellow oil. The oil was purified by 
column chromotography (30 g silica gel, 4:1 hexane/ethyl acetate). 
Fractions containing the suspected product were collected and rotovaped to 
produce a yellow oil, which was dried under vacuum. 
12
 
-Results and Discussion 
Synthesis ofBOC-L-Serine (18b). BOC-L-Serine (18b) was 
synthesized since it was rather expensive to purchase from Aldrich. 
One of difficulties run into was that there was no reference IR 
spectrum for this compound. Thus an IR spectrum of BOC-L-Serine 
from Aldrich was taken, and was used to compare with the spectrum 
of the synthesized product (Appendix A-I). One important feature of 
the spectrum is the carbonyl peak at 1755 cm- I . The carbonyl of the 
lactone (Appendix A-4) appears around 1830-1845 cm- I . A possible 
reason for the observed shift in carbonyl peaks can be accounted for 
by the existence of the keto and enol forms of serine. In the enol 
form, serine has a hydroxyl group where the carbonyl group existed. 
Thus, the resonance between these two forms would diminish the 
strength of the carbonyl bond in serine since in one of the forms it is 
only a single bond rather than a double bond. The serine carbonyl 
would be expected then to shift to a lower frequency since it is 
weaker than the carbonyl of the I)-lactone. For this to be hold as a 
valid explanation, the resonance forms would have to be more 
prevalent in serine than for the I)-lactone, which might or might not 
be true. 
Another possible explanation is that carboxylic acids in the 
solid state (KBr pellet) can dimerize via hydrogen bonding. The 
dimerization weakens the carbonyl bond, and shifts the peak to a 
lower frequency.l6 This shift in frequency was very valuable 
information because it identified whether the lactone ring existed or 
was broken open in the reactions where it was supposed to stay 
closed. 
Other characteristic features are the N-H peak and the O-H 
peak around 3420 cm- I . The same procedure of making a standard 
spectrum and comparing it to the spectrum of the synthesized 
product was repeated for the NMR spectra (Appendix A-2, A-3). 
Synthesis ofBOC-L-Serine fJ-Lactone (19b). For the synthesis of 
BOC-L-Serine I)-lactone (19b), the procedure from the Pansare et 
al.l4 was followed. One important tool that was helpful in identifying 
whether or not the lactone ring was still intact was the bright yellow 
spot it produced on a TLC plate after staining with bromocresol green 
and heating. The spot was distinctive because it did not tum yellow 
13 
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immediately, it changed color just before the plate was finished 
developing, which set it apart from anything else that was 
encountered. The IR spectrum (Appendix A-4) shows the 
characteristic carbonyl peak at 1844 cm-1, also indicating the 
presence of the lactone ring. 
Synthesis ofAnhydrous TsOH. Problems arose when attempting to 
dry the TsOH monohydrate to form the anhydrous acid. Several 
sources reported melting points for the anhydrous acid at 38 OC, 94­
95 OC, 104-105 OC; the melting point of the monohydrate was 104­
105 oC. The sources reporting the latter two melting points also 
synthesized the tosylate salt (20). Thus, it was not certain that it 
was even necessary to prepare the anhydrous acid since it appeared 
that one of the references successfully synthesized the tosylate salt 
(20) using the monohydrate, since their listed melting point for the 
anhydrous was the same as the monohydrate. lO 
The preparation of the anhydrous acid was attempted by two 
methods: 1) azeotropic distillation of the acid with benzene, and 2) 
heating the acid at 50 OC under vacuum for 4 hours. In both cases 
the monohydrate acid was obtained rather than the anhydrous acid. 
Dehydration did in fact occur during the distillaton because the water 
could be seen coming off in the arm opposite the sample flask, water 
being immiscible with benzene. However, the anyhydrous acid is 
extremely hygroscopic, and probably picked up water over the 
crystallization or the filtering processes. Preparation of the the 
anhydrous acid was attempted twice by this method and both 
attempts were unsuccessful. The monohydrate crystals melted and 
formed a block of solid when heating under vacuum, and became 
difficult to handle without exposing to the air for 2-3 minutes at a 
time. The melting point was taken and found to be 104-105 OC, so 
this method of dehydration was no more successful. Eventually, 
some crystals were used from the azeotropic distillation for the 
attempted synthesis of the tosylate salt (20) from CBZ ~-lactone 
(19a), which were the monohydrate acid. 
For the synthesis of the tosylate salt (20) from BOC ~-lactone 
( 19b), anhydrous TsOH was prepared successfully. The azeotropic 
distillation method was used, precipitating the anhydrous acid after 
distillation by the addition of excess benzene and cooling. In the first 
14
 
-attempt at preparation of the anhydrous acid, the distillate was 
rotovaped down and the product was recrystallized. In this attempt, 
no recrystallization was necessary since the acid was crystallied from 
the distillate. The extra handling and exposure to the air during the 
first attempt at making the anhydrous acid could have caused the 
anhydrous to pick up water again. The arthydrous acid was filtered 
and stored the crystals in a dessicator. A melting point of 94-95 OC 
was obtained. 
Attempted Synthesis of the Tosylate Salt (20) from CBZ-L-Serine f3­
Lactone (19a). The synthesis of the CHZ 13-lactone (19a) was 
completed successfully by a previous researcher. However, problems 
arose trying to make the tosylate salt (20) from CHZ-protected 13­
lactone. The IR spectrum from this reaction (Appendix A-8) shows a 
very prominent carboxyl peak at 3450 cm- l . This peak indicates 
that the lactone ring was hydrolyzed and broken open. Also, the 
shift in the carbonyl peak to the around 1740 cm- l was observed, 
supporting that conclusion. 
One possible cause for the broken ring was the quality of the 
reagents used. The presence of H20 from the monohydrate acid 
could have hydrolyzed the lactone ring. Also, it is possible that the 
methanol used was not properly dried. The methanol was dryed by 
stirring overnight in CaCI2. Although, we did take an IR spectrum of 
the lactone after stirring in methanol for 24 hours (Appendix A-9), 
and found that it was stable in the methanol used. Thus the 
methanol was probably not the source of the problem. 
Synthesis ofTosylate Salt (20) from BOC-L-Serine f3-Lactone (19b). The 
prominent feature on IR spectrum of the tosylate salt (20) (Appendix A­
S) is the carboxyl group peak at 3038 cm- I . This peak is a result of the 
TsOH, not the breaking open of the lactone. The carbonyl peak at 1834 
cm- l indicates that the lactone ring was still intact. Again, the successful 
synthesis of our compound was confirmed by comparing our data with the 
data of the reference. lO 
Attempted Synthesis of 9-Phenyfluorene-L-Serine f3-Lactone (21). The 
final part of the project was the attempted synthesis of N-protected 9­
15
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phenylfluorene-L-serine ~-lactone (21), which was probably not 
completed successfully. Upon inspection of the IR spectrum (Appendix A­
ID), it appeared that the lactone ring had broken open. The carbonyl peak 
was no longer around 1830 em-I, but at 1746 em-I, an indication that the 
lactone ring was no longer intact. It didn't make sense, though, that there 
was an alcohol peak rather than a carboxylic acid peak because an acid 
would have been formed had the ring been broken by water. It is 
uncertain at this point what product was formed. 
16
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Future Work 
The continuation of this project would attempt to synthesize 
the N-protected 9-phenylfluorene-L-serine ~-lactone( 21). It is 
uncertain what this reaction has produced thus far, with the results 
showing at this point that the lactone ring was broken open but an 
acid was not made. Once this reaction has been completed, the 
synthesis of the aldehyde( 22) seems promising after working with 
DIBAL-H in a model rxn, which successfully produced an aldehyde. 
17
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